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Abstract  
 2  The role of oxidative stress in the activating of downstream signalling leading to structural and  
 3  functional changes in the left ventricle of rabbits fed a high-fat diet for 12 wks and the effect of  
 4  dietary dehydroepiandrosterone supplementation, were analyzed. The animals showed  
 5  hyperglycemia, insulin-resistance, dyslipidemia and early features of cardiomyopathy, i.e. altered  
 6  myosin heavy-chain isoforrns, tissue degeneration and reduced contractility of the papillary muscle.  
 7  Dietary supplementation with dehydroepiandrosterone (0.02%,wt/wt) in these animals reduced  
 8  oxidative stress evaluated as levels of reactive oxygen species and hydroxynonenal levels, without  
 9  affecting high plasma glucose level or insulin resistance. Dehydroepiandrosterone supplementation  
 lO  also counteracted both the activation of redox-sensitive transcription factor and of nuclear  
 Il  trascription factor- kB, and the expression of tumor necrosis factor-alpha and of C-reactive protein-  
 12  mRNA. Improvement of the oxidative balance counteracted the shift to myosin heavy chain  
13  isoforrns, ameliorating the heart contractility. A high-fat diet induced oxidative stress and metabolic  
 14  syndrome in this rabbit model, and that dehydroepiandrosterone, by restoring oxidative balance,  
15  lowering lipid levels and down-regulating inflammation, prevented molecular and functional  
 16  aIterations of the cardiac muscle, thus exeterting a beneficaI effect and delaying the onset of diabetic  
17  cardiomyopathy.  
18  
  
 18  Introduction.  
 19  Diabetic cardiomyopathy is characterized by systolic and diastolic dysfunction and has been reported  
 20  in diabetic patients with no ischemic, vaIvuIar or hypertensive heart disease. Its development  
 21  includes metabolic disturbances, small-vessei diseases, autonomic dysfunction, insuIin-resistance and  
 22  myocardiai fibrosis (1,2). RecentIy, an important role in its pathophysiology has been attributed to  
 23  the generation of reactive oxygen species, which activates a number of secondary-messenger  
 24  pathways, finally Ieading to cardiac dysfunction (3-5). We recently showed recently that free radical  
 25  overproduction appears early in human type 2 diabetes (6) and that, in a rat model oftype l diabetes,  
 26  oxidative damage plays a key role in the early development of cardiomyopathy (7). Antioxidants  
 27  might counteract insulin resistance associated with type 2 diabetes and cardiovascular diseases (8-  
 28  lO). We reported elsewhere that in streptozotocin rats, the treatment with dehydroepiandrosterone  
 29  (DHEA), a compound that possesses multi-targeted antioxidant properties (11-15), prevents  
 30  myocardial damage induced by oxidative stress, while avoiding impairment of cardiac myogenic  
 31  factors and the switch to myosin heavy chain expression (16). DHEA also counteracts oxidative  
 32  imbalance and advanced glycation end-product formation in type II diabetic patients (7).  
 33  The study targets diabetic cardiomyopathy, in a model oftype 2 diabetes induced by a high-fat (HF)  
 34  diet in rabbits, an animaI species that is highIy susceptible to cardiovascular damage (17). Data show  
 35  that DHEA treatment counteracted biochernicai changes in the Ieft ventricle induced by oxidative  
 36  stress, improving myocardial function.  
37 Materials and methods  
38  Experimental procedure.  
39  Male New Zealand White rabbits, 15 wks oid (Harlan-ItaIy, Udine, Italy) weighing 3.0 -3.5 Kg were  
40  cared for in compliance with the Declaration of Helsinki as revised in 1983, the Italian Ministry of  
41  Health Guidelines (no. 86/609/EEC) and with the Princip!es 01 Laboratory Anima! Care (NIH no.  
42  85-23, revised 1985). The rabbits were acclimatized for 2 wks prior to the experiment in a room with  
43  12h 1ight dark cycle, individually housed in stainless stee1 cages in a temperature- and humidity-  
44  controlled room (23 ± 3°C, 50 ± 5%) and fed 100 g per day of standard rabbit non-purified diet,  
45  composition of 100 g: 16.2 g crude protein, 3.0 g crude fat, 7.3 g crude ash, 14.8 g fiber, 12 g  
46  moisture, added mineraI 2.1, 40U /kg vitamin E) with appropriate certificate from the Association of  
47  Official Agricultural Chemists, 1975, and relative procedure analyses (Laboratorio Dottori Piccioni,  
48  Gessate Milanese, Italy). Rabbits were randomly distributed into four groups. The control group (C)  
49  (n=4) received standard rabbit diet; the DHEA-alone treated group (C-D) (n=4) received the same  
50  diet supplemented with 0.02% DHEA (Sigma Aldrich, Milan, Italy); the high-fat group (HF) (n=4)  
51  received a high-fat diet, consisting of standard rabbit non purified diet, composition of 100g: 16.2 g  
52  crude protein, 7.3 g crude ash, 14.8 g fiber, 12 g moisture, added mineraI 2.1, 40U/kg vitamin E)  
53  plus lO g added fat (6.7g com oil and 3.3 g lard) (18); the HF plus DHEA group (HF-D) (n=4)  
54  received the high-fat diet supplemented with 0.02% DHEA. Two days before being killed, the  
55  rabbits were fasted'ovemight and the glucose tolerance test was performed. The rabbits were killed at  
56  3 mo from the start ofthe experiment, by aortic exsanguination after anesthetization with Zoletill00  
57  (Tiletamine-Zolazepam, Virbac, Carros, France). Blood was collected and plasma and serum were  
58  isolated. The heart was rapidly excised and weighed, and portions of left ventricle were taken to  
59  obtain nuclear and total extracts. Other heart portions were utilized for histological microscopy. The  
60  papillary musc1es were immediately removed for functional parameter detection.  
61  Generai parameters.  
62  Body weight and length of rabbits were measured at time zero and prior to death. The body mass  




65  Oral glucose tolerance test  
66  After a fasting peri od of 12h, a 50% glucose solution was orally administered to the rabbits at 1.5  
67  g/Kg. Blood samples were collected via the auricular artery before 15, 30, 45, 60, 90, 120 and 240  
68  min after glucose loading. Glucose levels were tested using an Accu-Check Compact kit (Roche  
69  Diagnostics Gmbh, Mannheim, Germany)  
  
70  Parameters in plasma.  
71  Triglyceride (TG), total cholesterol (Te), low density-lipoprotein (LDL)- and high-density-  
72  lipoprotein (HDL)-cholesterol were determined by standard enzymatic procedures using reagents kits  
73  (Hospitex Diagnostics, Florence, Italy). Aspartate aminotransferase (AST) and lactate dehydrogenase  
74  (LDH) were determined using an enzymatic kit (DiaSys Diagnostic Systems GmbH, Holzheim,  
75  Germany). Plasma insulin was measured with an ultrasensitive insulin enzyme-linked  
 76  immunosorbent assay kit rrom DRG Diagnostics (Marburg, Germany). Insulin sensitivity was  
 77  calculated using the homeostasis model assessment (HOMA): fasting glucose (mmol/L) x fasting  
 78  insulin (U/L)/22.5.  
 79  Tissue extracts (cytosolic, nuclear and total extracts).  
 80  Cytosolic and nuclear rractions rrom rabbit left ventricle were prepared by the Meldrum et al.  
 81  modified method (19). Briefly, left ventricle (100 mg) was homogenized at 10% (w/v) in a Potter  
 82  Elvehjem homogenizer (Wheaton Science Products, Millville, NJ, USA) using a homogenization  
 83  buffer. Homogenates were centrifuged at 1,000 g for 5 min at 4°C. Supematants were removed and  
 84  centrifuged at 15,000 g at 4°C for 40 min to obtain cytosolic rraction. The pellets were resuspended  
 85  in extraction buffer and incubated on ice for 30 min for high-salt extraction, followed by  
 86  centrifugation at 15,000 g for 20 min at 4 C. The resulting supematants containing nuclear proteins  
 87  were carefully removed and samples were stored at -80°C until use.  
 88  Total extract was obtained by homogenizing at 10% (w/v) directly with extraction buffer and were  
 89  centrifuged at 1,000 g for 5 min at 4°C. Supematants (total extract) were stored at -80°C until use.  
 90  Protein content was determined using the Bradford assay (20).  
 91  Oxidative biochemical parameters.  
 92  Reactive oxygen species (ROS) were measured in total extracts using 2',7' -dichlorofluorescein  
 93  diacetate (DCFH-DA) as a probe (21). Reduced and oxidized glutathione content was measured in  
 94  cytosolic fractions by Owens's method (22). The difference between total glutathione and GSH  
 95  content represents the oxidized glutathione (GSSG) content (expressed as flglmg proteins.); the ratio  
 
 96  between GSSG content and GSH is considered a good parameter of antioxidant status. 4-  
 97  hydroxynonenal (HNE) was detected by an HPLC procedure. The extract sample was directly  
 98  injected for HPLC (Waters Assoc., Milford, MA, USA) using an RP-18 column (Merck, Darmstadt,  
 99  Germany). The mobile phase used was 42% acetonitrilelbidistilled water (v/v). Serial concentrations  
 100  ofHNE (0.5-10 Ilmol/L) were used to prepare a standard curve (23). Catalase activity was evaluated  
 101  in the cytosolic fraction following Aebi's method (24). Total superoxide dismutase (SOD) activity  
 102  was assayed by the method described by Flohè and Otting (25). Since the activity of xanthine-  
 103  oxidase may vary, sufficient enzyme was used to produce a rate of cytochrome c reduction of at least  
 104  0.025 absorbance units/min in the assay without SODo  
 105  Advanced glycation end-products (AGE) detection with HPLC-MS.  
 106  Cytosol fractions were treated with 6 mol/L hydrochloric acid for 2 h at 40°C and then centrifuged  
 107  (1860 g) (26); only the supernatant was utilized. A Thermo-Finnigan Surveyor instrument (Thermo  
 108  Electron, Rodano, Milan, Italy) equipped with autosampler and PDA-UV 6000 LP detector was used.  
 109  Mass spectrometry analyses were performed using an LCQ Deca XP plus spectrometer, with  
 110  electrospray interface and ion trap as mass analyzer. The chromatographic separations were run on a  
111  Varian Polaris CI8-A column (150 x 2 mm, 3 /lm particle size) (Varian, Leinì, Turin, Italy). Flow  
 112  rate 200 IlL min-l. Gradient mobile phase composition was adopted: 95/5 to 0/100 v/v 5 mmol/L  
 113  heptafluorobutanoic acid in water/methanol in 13 min. The LC column effiuent was delivered to a  
 114  UV detector (200-400 nrn) and then to the ion source, using nitrogen as sheath and auxiliary gas  
 115  (Claind Nitrogen Generator apparatus, Lenno, Como, Italy). The source voltage was set to 4.5 kV in  
 116  the positive mode. The heated capillary was maintained at 200°C. The acquisition method used had  
 117  previously been optimized in the tuning sections for pentosidine quasi-molecular ion (capillary,  
 118  magnetic lenses and collimating octapole voltages) to maximize sensitivity. Collision energy (CE)  
 119  was chosen to maintain about lO % of the precursor ion. The tuning parameters adopted for the ESI  
 120  source were: source current 80.00 /lA, capillary voltage 3.00 V, tube lens offset 15 V; for ion optics,  
121  multipole 1 offset -5.25 V, inter multipole lens voltage -16.00 V, multipole 2 offset -9.00 V. Mass  
122  spectra were collected in tandem MS mode: MS
2
 of (+) 379 m/z with 33 % CE in the range 100-400  
123  m/z.  
124  Western blotting.  
125  NFkB-p65 on cytosol and nuclear extracts ofleft ventricle were detected by Laemmli's method (27).  
~-  
126  Anti-a-actinin antibodies served as loading contro l for cytosolic proteins and anti-Lamin-Bl for  
127  nuclear NFkB. Specific bands were quantified by densitometry using analytic software (Bio-Rad,  
128  Multi-Analyst, Munchen, Germany) and the net intensity of bands in each experiment was  
129  normalized for the intensity of the corresponding a-actinin or lamin-Bl bands, before comparison  
130  between control and treated samples.  
131  RNA isolation and RT -PCR .  
132  Total RNA was isolated using the RNA fast kit (Molecular Systems, San Diego, CA, USA). Total  
133  DNA was amplified using sense and antisense primers specific for the C-reactive protein (CRP) gene  
134  (sense 5'-AGGATCAGGATTCGTTTG-3' and antisense 5'-CACCACGTACTTGATATGTC-3'),  
135  the tumor necrosis factor alpha (TNFa) gene (sense 5'-AGGAAGAGTCCCCAAACAACCT-3' and  
136  antisense 5'-GGCCCGAGAAGCTGAT CTG), the myosin heavy-chain a (MHCa) gene (sense 5'-  
13 7  GCCAAGGTGAAGGAGA TGAA-3' and antisense 5' -CTCTCCTGGGTCAGCTTCAG-3 '), the  
138  myosin heavy-chain ~ (MHC~) gene (sense 5'-GGTCGAATACGTTACCATCTG-3' and antisense .  
139  5' -AA TCGCTGTCCACAGTGGTCG-3') or far the glyceraldehyde-3-phosphate dehydrogenase  
140  (GAPDH) gene (sense 5'-CGCCTGGAGAA AGCTGCTA-3' and antisense 5'-  
141  CCCCAGCATCGAAGG TAGA-3').  
142  The PCR reaction system contained lJlL ofRT product, 200 jlillol/L dATP, dGTP, dCTP and dTTP  
143  (Finnzymes, Espoo, Finland), 1.25 units of Taq DNA polymerase (Finnzymes, Espoo, Finland) and  
144  50 pmol of sense and antisense primers in a total volume of 50 JlL. AH experiments were performed  
145  on at least three independent cDNA preparations.  
  
146  PCR products were e1ectrophoresed on 2% agarose gels and amplification products were stained with  
147  GelStar nucleic acid gel stain (FMC BioProducts, Rockland, ME, USA). Ge1s were photographed  
148  and ana1yzed with Kodak 1D Image Analysis software. The net intensity ofbands in each experiment  
149  was normalized for the intensity of the corresponding GAPDHband before comparison between  
150  control and treated samples.  
151  Histological staining.  
152  For standard histology, portions of left ventric1e were fixed in 4% neutralized formalin. Fixed  
153  materia1 was processed for hematoxylin and eosin staining. Six-micron paraffin-wax sections of left  
154  ventric1e were used.  
155  Isolated papillary muscle and contractility determination.  
156  Papillary muscles were driven at constant frequency (120 beats/min) with a pair of electrodes  
157  connected to a 302 T Anapulse Stimulator via a 305-R Stimu1us Isolator (W.P. Instruments, New  
158  Haven, CT, USA) operating in constant current mode. Isometric twitches were evaluated by a  
159  Harvard transducer (60-2997), visualized on a Tektronix 2211 digital storage oscilloscope and  
160  continuously acquired and recorded in a Power Mac computer, using Labview Software (Nationai  
161  Instruments Corp., Austin, Texas, USA). The same software was used to measure developed peak  
162  mechanical tension (T max), maximum rate ofrise and faH ofdeveloped mechanical tension (+dT/dt  
163  max and -dT/dt max), time-to-peak mechanical tension (ttp) and duration of contraction.  
164  Statistical analysis.  
165  Results are expressed as means ± SD. ANOV A and post-hoc ana1yses inc1uded Bonferroni's test  
166  were used (28). The SPSS 14.0 package for Windows (SPSS Inc., Chicago, IL) was used for the  
167  statistical analysis. A value ofP<0.05 was viewed as statisticaHy significant.  
168 Results.  
 169  Generai features. Body weight, abdomen length, glucose and insulin were significantly increased in  
 170  rabbits fed a HP diet versus control values (P<0.05) after three months' treatment. DHEA  
 171  supplementation did not modify these value (TABLE 1). Body mass index (BM1) and HOMA were  
  
] 72  also significantly higher in HP rabbits than in controls (P<0.05) but not different rrom those of HF  
] 73  plus DHEA rabbits. The ratio heartlbody weight ratio was the same in all groups, whereas the heart  
] 74  weight of rabbit fed the HF increased vs controls; DHEA supplementation reduced this increase.  
175  The results ofthe glucose tolerance test are in FIG. 1. After oralloading, glucose levels remained a  
176  high level for up to 240 min, in the HP and DHEA treated HF groups. TG, TC and plasma LDL-  
] 77  cholesterol concentrations were significantly higher in HF rabbits versus controls (P<O.OI) and were  
] 78  lower in HF plus DHEA rabbits than in the HP alone group. (P<0.05). HDL-cholesterol was also  
] 79  significantly lower (P<O.O l) in the HF group versus controls; in the HF plus DHEA group its value  
]80  was similar to that of control animals (P<0.05).  
] 81  Oxidative parameters in the left ventricle.  
] 82  Rabbits fed a HP diet for 3 mo showed a significant increase in ROS levels in total extract of left  
183  ventricle vs the contro 1 group (P<O.OI). 4-hydroxynonenal, an end-product ofIipid peroxidation, also  
184  significantly increased in HP rabbits (P<O.OI) (FIGURE 2). In rabbits fed with HF plus DHEA, the  
185  ROS and HNE levels were significantly lower than in the HP rabbits (P<0.05). Moreover, total SOD  
186  and catalase activities were also increased in the HP rabbits, and DHEA supplementation partially  
187  restored these activities to control levels. No significant difference in the GSSG/GSH ratio was  
188  observed among groups (data not shown). The leve l ofpentosidine was significantly lower in the HF  
189  plus DHEA than in the HF alone group (P<0.05) (TABLE l). In samples rrom both control and  
190  DHEA groups, gas-mass-HPLC analysis failed to detect any peak for pentosidine, apparently  
191  indicating its absence in these animals.  
192  NFkB-p65.  
193  Westem Blot analysis detected NFkB-p65 protein in the nuclear and the cytosolic rractions of left  
194  ventricle (FIGURE 3, panel A and panel B). Nuclear p65-NFkB of HF rabbits was increased  
195  versus the contro l groups (P<0.05) (panel A) while p65-NFkB protein was reduced in the cytosolic  
196  rraction of HF rabbits (P<0.05) (panel B). In the rabbits fed the HF plus DHEA diet, cytosolic p65  
197  protein content was less markedly reduced than it was in the HF group, corresponding to an increase  
  
 198  of the nuclear level of p65, and thus indicating 10wer activation of the NFkB transcription factor  
 199  (P<0.05).  
 200  Inflammatory parameters.  
 201  Both indices ofthe proinflammatory state, TNF-a and CRP, weresignificantIy increased in the heart  
 202  ofrabbits fed the HF diet (P<O.OI) (TNFa-: FIGURE 3, panel C and CRP: FIGURE 3, panel D).  
 203  The HF plus DHEA diet significantly decreased expression of both TNF-a. and CRP, vs the HF  
 204  group (P<0.05).  
 205  Myosin expression.  
 206  PCR analysis was used to evaluate expression of two isofonns (a and ~) of the myosin heavy-chain  
 207  (MHC) protein (FIGURE 4) in the Ieft ventricle of control, DHEA, HF and HF plus DHEA rabbits.  
 208  The HF diet detennined a significantly (P<O.OI) decreased expression of a-MHC and an increased  
 209  expression of ~-MHC. When DHEA was added to the HF diet, a-MHC was brought closer to the  
 210  controi value, and ~-MHC was reduced versus the contro 1 value (P<0.05).  
 211  Necrosis markers  
 212  LDH and AST release were evaIuated in the plasma (FIGURE 5). Both LDH (panel A) and AST  
 213  (panel B) significantly increased in HF rabbits (P<O.OI). In the HF plus DHEA rabbits, the levels of  
 214  LDH and AST were significantly lower than in the HF alone rabbits (P<0.05).  
 215  HistoIogicaI anaIysis.  
 216  In the Ieft ventricle of the HF rabbits, histological preparations clearly showed extensive and diffuse  
 217  lipid deposition (FIGURE 6, panel C). This lipid infiltration was not observable in either the control  
 218  or the DHEA alone group (panel A and panel B). Tissues obtained from HF plus DHEA rabbits  
 219  (panel D) showed rare areas of slight lipid deposition.  
 220  Cardiac function.  
221  The contractile force developed by electrically-driven papillary muscles was evaluated in basaI  
 222  conditions (TABLE 2). BasaI contractility was weaker in papillary muscles from HF rabbits versus  
  
223  controls; this was evident not only for maximal developed mechanical tension (Tmax: P<O.OI by  
224  ANOV A), but also for maximum rate of rise (+dT/dtmax; P<O.Ol) and maximum rate of fall of  
225  developed mechanical tension (-dT/dtmax; P<0.01). In contrast, no significant difference was found  
226  between papillary muscles rrom control and HF rabbits in regard to time to peak mechanical tension  
227  (TPT) or duration of contraction. Treatment with DHEA significantly reduced the effects of the HF  
228  diet (P<0.05). However, DHEA did not per se affect contractile properties ofthe papillary muscles.  
229 Discussion  
230  Male New Zealand rabbits fed a HF diet for 3 mo developed abdorninal obesity, hyperglycemia,  
231  insu1in-resistance, dyslipedernia, and cardiac dysfunction. DHEA supplementation did not affect the  
232  high plasma glucose levels induced by the HF diet, nor did it protect against hyperinsulinemia or the  
233  HOMA index. There is conflicting evidence about the effect of supplemental DHEA on glucose  
234  metabolism and insulin-sensitivity in healthy human subjects (29,30): our results are in agreement  
235  with several human studies showing only slight or no effect of DHEA on glucose homeostasis (31-  
236  33). As far as the plasma lipid profile is concemed, when DHEA was added to the HF diet, HDL  
237  increased in the plasma while triglycerides, total cholesterol and LDL were reduced. These resu/ts  
238  are in agreement with studies reporting that DHEA decreases serum triglycerides and the body  
239  weight in hyperlipidemic rats and diabetic mice (34,35). The mechanisms whereby DHEA exerts its  
240  anti-lipid effects are incompletely understood. However, it has been reported that the anti-obesity  
241  effect ofDHEA may in part be related to changes in lipase activity and in beta-adrenergic receptor  
242  density (36,37). Moreover, DHEA accelerates lipid catabolism by direct regulation of hepatic lipid  
243  metabolism (38) and also has antiglucocorticoid activity, caused by direct modulation of the hepatic  
244  glucocorticoid receptor (39).  
245  However, alongside its effects on lipid metabolism and on insulin axis, we believe that DHEA's key  
246  action is against oxidative imbalance (6,7). Indeed, DHEA counteracted the increase in glycoxidative  
247  products observed in the plasma ofrabbits fed a HF diet, in agreement with a previous rat study (13-
248  16). Oxidative stress was also observed in the cardiac tissue of HF rabbits, in which there were  
  
249  significant increases in ROS, end-products of lipid peroxidation (HNE) and activation of  
250  transcription factor NFkB. Activation of NFkB, which triggers in the inflammatory cascade, was  
251  demonstrated by the increased expression of TNF -alpha and CRP in cardiac tissue. Here we show  
252  that DHEA, by decreasing oxidative stress and reducing activationofNFkB transcription factor; may  
253  could determine a reduced expression of TNF and of CRP. Moreover, the anti-inflammatory effects  
254  of DHEA, due to cytokine reduction caused by decreased NFkB activation, might be amplified by  
255  the reduction of cholesterollevels, which in tum directly decreases CRP secretion from the tissues  
256  (40). CRP has been shown to predict morbidity and mortality from coronary heart disease (41).  
257  Moreover, it has been shown that high dietary cholesterol intake can increase the production of  
258  atherogenic inflammatory cytokines, such as IL-6 and TNF-a, and that reducing dietary cholesterol  
259  concentration leads to a reduction in CRP production (42).  
260  We suggest that the pro-oxidant and inflammatory states, observed in HF rabbits, cause activation of  
261  intracellular signaling responsible for impaired myocardial function, as been reported in cases of  
262  heart failure (43). HP rabbits showed a switch of cardiac heavy-chain myosin from the alpha to the  
263  beta isoform: this event comprises the heart's "molecular motor" because contractile properties  
264  depend to a great extent on the isoform composition of MHC proteins. A switch in MHC isoforrn  
265  composition has been reported to cause reduced contractile velocity and energy expenditure (44). In  
266  man as in animals, a reduced content of a-MHC, which is expressed exclusively in the myocardium,  
267  has been reported to be responsible for the reduced myocardial contractility during heart failure (45)  
268  and in diabetes (46). In a previous model of type I diabetes cardiomyopathy (7), we reported that  
269  DHEA treatment, by avoiding impairment of cardiac myogenic factors and producing a switch in  
270  MHC gene expression, protected against tissue damage, an early event in diabeti c cardiomyopathy.  
271  DHEA's modulatory effects on MHC expression were also observed in HP rabbits: expression of  
272  two isoforms, alpha and beta, in DHEA treated rats were not significantly different from those ofthe  
273  controi group.  
  
274  Rabbits on a HF diet clearly showed alterations in papillary muscle contractility. This was shown by  
275  altered basaI contractility, including reduced maximal developed tension, maximum rate ofrise, and  
276  maximum rate of fall of developed tension, which are signs of diastolic dysfunction. As in the case of  
277  rat cardiac muscle (7), these alterations ofthe mechanisms controlling intracellular calcium handling  
278  within cardiac myocytes are probably related to the structural damage caused by the HF diet.  
279  Histological analysis of tissue ftom HF rabbits showed extensive and diffuse lipid deposition, as  
280  reported in other animaI models (47). The increased release ofLDH and AST in the plasma ofH.F.  
281  rabbits confirmed myocardial damage. Treatment with DHEA protects the cardiac tissue ftom this  
282  altered basaI contractility, as well as minimizing histological changes and reducing cells damage  
283  caused by the HP diet.  
284  The role of DHEA in the cardiovascular system has been highlighted by the recent finding, in the  
285  human heart, of DHEA production and CYP-17 gene expression, a key factor in DHEA synthesis  
286  (48,49) and it has recently been proposed that the vascular protective effect of DHEA might be  
287  dependent on G-a-GTP-binding protein mediated activation ofthe phosphatidil-inositoI3-kinase/ Akt  
288  signaling pathway (50). Several explanations have been put forth for the multi-targeted antioxidant  
289  effects of DHEA, including its effect on catalase expression (51), and its up-regulation of the  
290  thioredoxin system (52), of the fatty-acid composition of cellular membranes and of cytokine  
291  production. However, the precise mechanisms remain to be clarified, and additional non-antioxidant  
292  effects cannot yet be ruled out. Whether the effect ofDHEA is due to DHEA itself, to its metabolites,  
293  or to a combination of both remains unclear. DHEA is also considered to be a pre-hormone, and it  
294  has been speculated that, through hormonal effects it might modulate several metabolic pathways  
295  which have nothing to do with antioxidant function. However, we found negligible variations of  
296  either 17 ~-estradiol or testosterone concentrations in rats treated with 4 mg DHEA. Nevertheless,  
297  we report elsewhere that DHEA, but not a variety of other steroids including ~-estradiol, ADIOL and  
298  dihydrotestosterone, protects bovine retinal capillary pericytes against glucose-induced lipid  
299  peroxidation (53).  
  
300  In conclusion, we show that DHEA supplementation can prevent molecular and functional alterations  
301  of the cardiac muscle, restoring oxidative balance and lowering lipid levels, in rabbit fed a high-fat  
302  diet. Since similar results have been reported in a model of diabetes type I diabetes, we suggest that  
303  heart damage is chiefly dependent on impaired glucose metabolism, and not on insulin-resistance.  
304  These data, together with our recent observations on type Il diabetes patients (6), suggest that DHEA  
305  treatment might prevent many events that lead to the cellular damage induced by hyperglycemia,  
306  thus delaying the onset or progression of cardiac complications in type Il diabetes.  
 
